Urgent.News

What's breaking now, across thousands of outlets.

World

Samsung Electronics names new heads of memory, mobile businesses

Samsung Electronics on Friday promoted three executives to president in its chipmaking Device Solutions (DS) Division, signaling a generational shift in leadership by elevating executives who spearheaded record semiconductor earnings. The company said Friday it promoted Executive Vice President Hwang Sang-joon to head of its memory business unit and president. Jo Sang-yeon, executive vice…

Samsung Electronics names new heads of memory, mobile businesses

Samsung Electronics announced on Friday that it has promoted three executives to the position of president within its Device Solutions (DS) Division, indicating a change in leadership. The company revealed that Executive Vice President Hwang Sang-joon will now head the memory business unit and serve as president. Jo Sang-yeon, who was previously the executive vice president and head of Device Solutions America, has been promoted to president and head of the System LSI Business.

Additionally, Lee Jong-myung, executive vice president and head of process development at the Semiconductor Research Institute, has been appointed president and chief technology officer of the DS division. Furthermore, President Choi Won-joon, who leads the Mobile Experience (MX) business under the Device Experience (DX) Division, has been designated as the head of this business.

With these changes, the two CEOs of Samsung Electronics, Jun Young-hyun, head and vice chairman of the DS Division, and Roh Tae-moon, president of the DX Division, will concurrently assume leadership roles in the Memory Business.

Written by urgent.news from The Korea Times's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.

Other reports of this story

Every outlet that reported this, and when →

Read the original at koreatimes.co.kr →

More in World

German Court Overturns Keytruda SC Sales Ban, Opening Door to European Expansion

The path to market entry in Germany, Europe’s largest pharmaceutical market, has opened for Keytruda SC, the subcutaneous formulation of the immuno-oncology drug developed by U.S.-based Merck (MSD)…

  • German court overturns ban on Keytruda SC sales, allowing European expansion.
  • Merck wins patent disputes in Germany and U.S., clearing path for drug's entry.
  • Keytruda SC's subcutaneous formulation reduces treatment time to one to two minutes.

More from Friday 20 November →